X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Mostafa Adam S. | Chief Financial Officer | Mar 11 '24 | Sale | 0.88 | 52,500 | 46,347 | 0 | Mar 11 05:19 PM | Ragan Paula | President and CEO | Mar 11 '24 | Sale | 0.88 | 49,678 | 43,856 | 765,068 | Mar 11 05:20 PM | DiBiase Mary | Chief Operating Officer | Mar 11 '24 | Sale | 0.88 | 15,409 | 13,591 | 291,752 | Mar 11 05:19 PM | Taveras Arthur | Chief Scientific Officer | Mar 11 '24 | Sale | 0.88 | 14,235 | 12,552 | 234,301 | Mar 11 05:20 PM | Mostafa Adam S. | Chief Financial Officer | Feb 12 '24 | Sale | 1.01 | 27,721 | 27,973 | 52,500 | Feb 12 05:03 PM | Ragan Paula | President and CEO | Feb 12 '24 | Sale | 1.01 | 21,695 | 21,892 | 814,746 | Feb 12 05:05 PM | DiBiase Mary | Chief Operating Officer | Feb 12 '24 | Sale | 1.01 | 3,683 | 3,709 | 307,161 | Feb 12 05:23 PM | Taveras Arthur | Chief Scientific Officer | Feb 12 '24 | Sale | 1.01 | 787 | 793 | 248,536 | Feb 12 05:23 PM | Ragan Paula | President and CEO | Nov 03 '23 | Sale | 0.90 | 39,906 | 35,915 | 836,441 | Nov 03 05:26 PM | Mostafa Adam S. | Chief Financial Officer | Nov 01 '23 | Sale | 0.73 | 230,645 | 168,371 | 80,221 | Nov 03 04:42 PM | Ragan Paula | President and CEO | Nov 01 '23 | Sale | 0.73 | 199,531 | 145,658 | 876,347 | Nov 03 05:26 PM | DiBiase Mary | Chief Operating Officer | Nov 01 '23 | Sale | 0.73 | 67,695 | 49,417 | 310,844 | Nov 03 04:40 PM | Taveras Arthur | Chief Scientific Officer | Nov 01 '23 | Sale | 0.73 | 67,695 | 49,417 | 249,323 | Nov 03 04:39 PM | Baldry Mark | Chief Commercial Officer | Nov 01 '23 | Sale | 0.73 | 10,257 | 7,488 | 24,690 | Nov 03 04:39 PM | DiBiase Mary | Chief Operating Officer | Sep 08 '23 | Sale | 1.25 | 2,642 | 3,300 | 147,894 | Sep 12 04:04 PM | WYZGA MICHAEL S | Director | Aug 18 '23 | Buy | 1.20 | 25,000 | 29,875 | 76,667 | Aug 22 04:09 PM | Stewart Murray | Interim Chief Medical Officer | Aug 10 '23 | Sale | 1.06 | 130,056 | 137,859 | 146,504 | Aug 11 07:26 PM | Mostafa Adam S. | Chief Financial Officer | Jun 30 '23 | Sale | 1.89 | 2,641 | 4,991 | 80,221 | Jul 05 04:04 PM | DiBiase Mary | Chief Operating Officer | Jun 30 '23 | Sale | 1.89 | 464 | 877 | 150,536 | Jul 05 04:05 PM | Ragan Paula | President and CEO | Jun 23 '23 | Sale | 1.92 | 6,724 | 12,910 | 543,797 | Jun 26 04:11 PM | Mostafa Adam S. | Chief Financial Officer | Jun 23 '23 | Sale | 1.93 | 5,417 | 10,455 | 82,862 | Jun 26 04:13 PM | DiBiase Mary | Chief Operating Officer | Jun 23 '23 | Sale | 1.93 | 857 | 1,654 | 151,000 | Jun 26 04:15 PM | Ragan Paula | President and CEO | Jun 15 '23 | Sale | 2.23 | 6,724 | 14,995 | 550,521 | Jun 16 04:15 PM | Mostafa Adam S. | Chief Financial Officer | Jun 15 '23 | Sale | 2.22 | 5,417 | 12,026 | 88,279 | Jun 16 04:17 PM | DiBiase Mary | Chief Operating Officer | Jun 15 '23 | Sale | 2.23 | 857 | 1,911 | 151,857 | Jun 16 04:24 PM | Ragan Paula | President and CEO | May 31 '23 | Sale | 1.95 | 6,292 | 12,269 | 557,245 | May 31 05:05 PM |
|